Speaker illustration

Mr Joris Komen

Institute for Pharmaceutical Sciences, Utrecht (Netherlands (The))

Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Stroke prevention in atrial fibrillation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb